Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CFA

Financiado

Cerrado

The Clinical Flexible Analyzer a new generation IVD testing device aimed to inc...

The Clinical Flexible Analyzer a new generation IVD testing device aimed to increase the competitiveness of local healthcare vs. large laboratories Increasing population and rise in chronic diseases have led to an enormous demand for faster and better in-vitro diagnostic tests of parameters for improved detection and cure of diseases. However, there is significant fragmentati... ver más

28/02/2019

MEON Medical

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

MEON MEDICAL SOLUTIONS GMBH CO KG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-02-28

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

MEON Medical

50.00K€ | Lider

TECNOLOGIA SEÑALETICA

289.28K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

spinitCompanion A point of care device to provide real time blood analysis f... 71K€ Cerrado

PDC2021-120957-I00 PLATAFORMA PARA EL DESARROLLO RAPIDO DE TESTS DE DIAGNOTICO... 150K€ Cerrado

X-10 Pathology X 10 Pathology Empowering diagnostics 71K€ Cerrado

UNI 20150005 DISEÑO Y DESARROLLO DE REACTIV... UNI 20150005 DISEÑO Y DESARROLLO DE REACTIVOS Y SISTEMA AU... 1M€ Cerrado

EUIN2013-50894 PLATAFORMA MULTIPLEXADA PARA EL DIAGNOSTICO DE ENFERMEDADES... 15K€ Cerrado

HemaXis DX A patient friendly blood collection device that produces pur... 71K€ Cerrado

Duración del proyecto: 3 meses Fecha Inicio: 2018-11-19
Fecha Fin: 2019-02-28

Líder del proyecto

MEON MEDICAL SOLUTIONS GMBH CO KG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Increasing population and rise in chronic diseases have led to an enormous demand for faster and better in-vitro diagnostic tests of parameters for improved detection and cure of diseases. However, there is significant fragmentation and separation in the IVD immunochemical analyzers market, depending on the end users’ size: on one hand there are large workstations (analyzers) capable of analyzing several parameters in one device, which are extremely large and pricey, and on the other hand, there are stand-alone devices with much narrower parameter testing, low throughput and efficiency, which are mainly based on 30 years old technology. These latter are the only option for smaller local clinics, which cannot afford the large, combined workstations, and thus, lose competitiveness to large laboratories who can afford them. Our company, MEON Medical Solutions, is an Austrian based SME specialized in developing IVD medical devices for measurement of vital parameters to support medical professionals in clinical diagnostics. Our over 30 years of experience in the field enabled us to identify the business opportunity derived from the needs of small clinics and laboratories, for which we have developed the CFA – Clinical Flexible Analyzer- i.e. an innovative, automated, all-in-one immunochemical analyzer that combines the three most demanded diagnostic methods - Clinical Chemistry, Heterogeneous Immunoassays and Ion Selective Electrodes - in a single small modular, highly flexible and cost-efficient device. The CFA will enable small laboratories to provide an extremely cost-efficient local healthcare, and boost the growth of our company: We have estimated that after 5 years of CFA’s commercial launch in 2022, we will have engaged into 1,000 small clinics and hospitals globally, boosting the economic growth of our company, and enabling us to achieve a leading position over all other competitors.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores